Eagle’s Eye View: Day 2 — ACCess Points Daily Wrap Up | AHA 2023
Drs. Kim Eagle, Dharam Kumbhani, Payal Kohli, and Ajay Kirtane review the late-breaking clinical trials from day 2, Sunday, November 12 at the American Heart Association Scientific Sessions 2023 including AZAELEA-TIMI 71 (0:38), ARTESIA (5:07) and REPRIEVE (7:52). The ACC is providing coverage of the latest science being presented at AHA 2023 in Philadelphia. For trial summaries, news coverage, daily video wrap-ups and more, visit ACC's Meeting Coverage Page. Follow the ACC on Social Media and use the hashtag #AHA23.
Clinical Topics: Arrhythmias and Clinical EP, Atrial Fibrillation/Supraventricular Arrhythmias, Anticoagulation Management, Stable Ischemic Heart Disease, Vascular Medicine
Keywords: American Heart Association, AHA23, EaglesEyeView, Anticoagulation Management, Atrial Fibrillation, Stroke, Biomarkers, HIV, Vascular Diseases